Art

J-GLOBAL ID：202302234582663921   Reference number：23A2949171

Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis

SARS-CoV-2とMycobacterium tuberculosis間の免疫相互作用【JST・京大機械翻訳】

Author (16)： Booysen Petro (1Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa) ,  Booysen Petro (2Department of Medicine, University of Cape Town, Cape Town, South Africa) ,  Wilkinson Katalin A. (1Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa) ,  Wilkinson Katalin A. (2Department of Medicine, University of Cape Town, Cape Town, South Africa) ,  Wilkinson Katalin A. (3Tuberculosis Laboratory, The Francis Crick Institute, London, United Kingdom) ,  Sheerin Dylan (4Infectious Diseases and Immune Defence Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, VIC, Australia) ,  Sheerin Dylan (5Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia) ,  Waters Robyn (1Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa) ,  Waters Robyn (2Department of Medicine, University of Cape Town, Cape Town, South Africa) ,  Coussens Anna K. (1Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa) ,  Coussens Anna K. (4Infectious Diseases and Immune Defence Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, VIC, Australia) ,  Coussens Anna K. (5Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia) ,  Wilkinson Robert J. (1Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa) ,  Wilkinson Robert J. (2Department of Medicine, University of Cape Town, Cape Town, South Africa) ,  Wilkinson Robert J. (3Tuberculosis Laboratory, The Francis Crick Institute, London, United Kingdom) ,  Wilkinson Robert J. (6Department of Infectious Diseases, Imperial College, London, United Kingdom)
Material： Frontiers in Immunology (Web)
Volume： 14  Page： 1254206  Publication year： 2023 
JST Material Number： U7074A  ISSN： 1664-3224  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： SARS-CoV-2 and Mycobacterium t...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=23A2949171&from=J-GLOBAL&jstjournalNo=U7074A") }}

Thesaurus term： *interaction ,  tuberculosis ,  mortality ,  human(primates) ,  mouse(animal) ,  *immunity ,  immunological reaction ,  *Mycobacterium tuberculosis ,  T cell ,  *Mycobacterium ,  macrophage ,  immunologic disease ,  neutrophils ,  monocyte
Semi thesaurus term： 炎症反応 , 【Automatic Indexing@JST】

Author keywords (8)： COVID-19 ,  latent TB ,  LTBI ,  Bacille Calmette Guerin ,  co-infection ,  immune response ,  transcriptomics ,  T cells

JST classification (2)： Infectious diseases,parasitics diseases in general.  (GD01010H) ,  Basic research of immunotherapeutic agents and blood preparations  (GW22010D)

Reference (75)：

• WHO. Global tuberculosis report 2022 (2022). Available at: https://wwwwhoint/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022.
• WHO. Available at: https://covid19.who.int/.
• Hyams C, Challen R, Marlow R, Nguyen J, Begier E, Southern J, et al. Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom. Lancet Regional Health - Europe (2023) 25:100556. doi: doi: 10.1016/j.lanepe.2022.100556
• Pai M, Kasaeva T, Swaminathan S. Covid-19’s devastating effect on tuberculosis care - A path to recovery. N Engl J Med (2022) 386(16):1490-3. doi: doi: 10.1056/NEJMp2118145
• Benade M, Long L, Meyer-Rath G, Miot J, Evans D, Tucker J-M, et al. Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data. PloS Global Public Health (2022) 2(10):e0000559. doi: doi: 10.1371/journal.pgph.0000559

Terms in the title (4)： SARS-CoV-2 ,  Mycobacterium ,  免疫 ,  相互作用